Literature DB >> 6690050

Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with high familial incidences of cancer.

D R Strayer, W A Carter, S D Mayberry, E Pequignot, I Brodsky.   

Abstract

The possible role that natural cell-mediated cytotoxicity may play as a host defense mechanism against malignant tumors was investigated. We measured natural cell-mediated cytotoxicity (51Chromium released) in 79 normal individuals using K562 leukemia cells as targets in quadruplicate assays after 3, 4, and 5 hr of incubation using three different effector:target cell ratios (6.2:1, 25:1, and 50:1). Natural cell-mediated cytotoxicity was significantly lower (p less than 0.005) in each of the nine separate assay conditions for individuals with a high familial incidence of cancer compared to individuals with a low incidence of cancer. Moreover, natural cell-mediated cytotoxicity inversely correlated with the number of family members with cancer. The relationship between high familial cancer incidence and low natural cell-mediated cytotoxicity was observed in males as well as in females and in nonsmokers as well as in smokers. The same conclusion was reached whether the data were expressed as percentage of 51Chromium released, as lytic units per 10(7) mononuclear cells, or as lytic units per ml of peripheral blood. Thus, defects in natural cell-mediated cytotoxicity may play a role in the initial stages of human tumorigenesis. It may also be possible to identify individuals at increased risk of cancer development.

Entities:  

Mesh:

Year:  1984        PMID: 6690050

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

1.  Non-Hodgkin's lymphoma in rheumatoid arthritis.

Authors:  D Porter; R Madhok; H Capell
Journal:  Ann Rheum Dis       Date:  1991-05       Impact factor: 19.103

2.  Natural killer activity in patients with chronic hepatitis treated with OK432, interferon, adenine arabinoside and glycyrrhizin.

Authors:  T Wada; T Arima; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1987-06

3.  Modulation of cellular immunity in medical students.

Authors:  J K Kiecolt-Glaser; R Glaser; E C Strain; J C Stout; K L Tarr; J E Holliday; C E Speicher
Journal:  J Behav Med       Date:  1986-02

4.  Natural killer activity of peripheral blood lymphocytes and its relation to histopathological factors of lung cancer.

Authors:  A Terazawa; N Tanaka; N Senou; F Inoue; H Matsuura; A Gouchi; S Fuchimoto; H Mimura; K Orita
Journal:  Jpn J Surg       Date:  1987-07

Review 5.  Breast cancer and the immune system.

Authors:  Leanna J Standish; Erin S Sweet; Jeffrey Novack; Cynthia A Wenner; Carly Bridge; Ana Nelson; Mark Martzen; Carolyn Torkelson
Journal:  J Soc Integr Oncol       Date:  2008

6.  Depressed level of natural killer cells in cancer family syndrome.

Authors:  G Guanti; S Massari; G Cristofaro; M L Caruso; R Porsia; A Stella; F Susca; A Tauro; I Giorgio
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 7.  Psychosocial factors in the development and progression of breast cancer.

Authors:  L Hilakivi-Clarke; J Rowland; R Clarke; M E Lippman
Journal:  Breast Cancer Res Treat       Date:  1994-02       Impact factor: 4.872

8.  Lysis of fresh murine mammary tumor cells by syngeneic natural killer cells and lymphokine-activated killer cells.

Authors:  I H Ames; C E Gates; A M Garcia; P A John; A K Hennig; R H Tomar
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

9.  Familial occurrence of breast cancer is associated with reduced natural killer cytotoxicity.

Authors:  D R Strayer; W A Carter; I Brodsky
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

10.  Natural killer cell activity in patients with pernicious anemia.

Authors:  J A Vargas; M Alvarez-Mon; L Manzano; A Albillos; A Fernández-Corugedo; J C Gea-Banacloche; F M Gonzalez; A Durántez
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.